BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2022
View Archived Issues
Down syndrome linked to senescence-like state
Read More
Identification of novel drug candidates targeting dengue virus capsid protein
Read More
Indirect radiolabeling of pGlu for intratumoral delivery of alpha- and beta-particle emitters
Read More
Novel roe-inspired MSC microcapsules for the treatment of IBD
Read More
Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis
Read More
Tucatinib plus anti-HER2 antibody NSCs prolong survival of mice with brain-metastatic breast cancer
Read More
Dana-Farber Cancer Institute patents UCP1 activators
Read More
The Vanderbilt University divulges new muscarinic M5 receptor antagonists
Read More
Gossamer Bio presents DGKA and/or DGKZ inhibitors
Read More
Incyte synthesizes new JAK2 V617F inhibitors
Read More
Volastra Therapeutics identifies ENPP1 inhibitors
Read More
NHMRC grant supports exploration of Pharmaxis serine protease inhibitor for tissue repair
Read More
Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems
Read More
MAP3K7 modulation to treat MDS-associated anemia
Read More
Pfizer and Beam Therapeutics collaborate to advance in vivo base editing programs
Read More
EsoCap and Upadia sign licensing agreement to develop therapeutics to treat Barrett's esophagus
Read More
Cullinan collaborates with Mount Sinai to develop HPK1 protein degraders for cancer
Read More